Skip to main content

Table 2 Crude and adjusted treatment outcomes

From: Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania

Treatment outcome

ALU (N = 114)

DHP (N = 89)

ETF

0 (0%)

0 (0%)

LCF, n (%)

1 (0.88%)

0 (0%)

LPF, n (%)

5 (4.39%)

1 (1.12%)

ACPR, n (%)

108 (94.74%)

88 (98.88%)

PCR corrected

  

 ETF

0

0

 LCF, n (%)

1 (0.88)

0

 LPF, n (%)

4 (3.54)

1 (1.12)

 ACPR, n (%)

109 (95.58)

88 (98.88)

Parasite persistence

  

Positive blood smear

  

 Day 1, n (%)

50 (43.10)

36 (40.45)

 Day 2, n (%)

3 (2.59)

1 (1.12)

 Day 3, n (%)

0

0